Literature DB >> 17695569

Fibromyalgia.

Sangita Chakrabarty1, Roger Zoorob.   

Abstract

Fibromyalgia is an idiopathic, chronic, nonarticular pain syndrome with generalized tender points. It is a multisystem disease characterized by sleep disturbance, fatigue, headache, morning stiffness, paresthesias, and anxiety. Nearly 2 percent of the general population in the United States suffers from fibromyalgia, with females of middle age being at increased risk. The diagnosis is primarily based on the presence of widespread pain for a period of at least three months and the presence of 11 tender points among 18 specific anatomic sites. There are certain comorbid conditions that overlap with, and also may be confused with, fibromyalgia. Recently there has been improved recognition and understanding of fibromyalgia. Although there are no guidelines for treatment, there is evidence that a multidimensional approach with patient education, cognitive behavior therapy, exercise, physical therapy, and pharmacologic therapy can be effective.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17695569

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  20 in total

1.  Effects of Vitamin D Therapy on Quality of Life in Patients with Fibromyalgia.

Authors:  Atalay Dogru; Ayse Balkarli; Veli Cobankara; Sevket Ercan Tunc; Mehmet Sahin
Journal:  Eurasian J Med       Date:  2017-06

2.  Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study.

Authors:  Omer Faruk Sendur; Yasemin Turan; Engin Tastaban; Cigdem Yenisey; Mukadder Serter
Journal:  Rheumatol Int       Date:  2008-10-14       Impact factor: 2.631

Review 3.  Fibromyalgia and nutrition, what do we know?

Authors:  Laura-Isabel Arranz; Miguel-Angel Canela; Magda Rafecas
Journal:  Rheumatol Int       Date:  2010-04-01       Impact factor: 2.631

Review 4.  Pregabalin: a review of its use in fibromyalgia.

Authors:  Katherine A Lyseng-Williamson; M Asif A Siddiqui
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Traumatic experiences, major life stressors, and self-reporting a physician-given fibromyalgia diagnosis.

Authors:  Mark G Haviland; Kelly R Morton; Keiji Oda; Gary E Fraser
Journal:  Psychiatry Res       Date:  2010-04-10       Impact factor: 3.222

6.  Rapid diagnosis and treatment of severe tricyclic antidepressant toxicity.

Authors:  Simon Clark; Jerry W Catt; Terrell Caffery
Journal:  BMJ Case Rep       Date:  2015-10-14

7.  Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies.

Authors:  Stephen Brunton; Fujun Wang; S Beth Edwards; Antonio S Crucitti; Melissa J Ossanna; Daniel J Walker; Michael J Robinson
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

8.  Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia.

Authors:  Robert H Palmer; Antonia Periclou; Pradeep Banerjee
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

Review 9.  Duloxetine: in patients with fibromyalgia.

Authors:  Monique P Curran
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

Review 10.  Effects of obesity on function and quality of life in chronic pain conditions.

Authors:  Laura-Isabel Arranz; Magda Rafecas; Cayetano Alegre
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.